UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Commensal Clostridia: leading players in the maintenance of gut homeostasis

Gut pathogens, 2013-08, Vol.5 (1), p.23-23

2013

Volltextzugriff (PDF)

IL-33 promotes recovery from acute colitis by inducing miR-320 to stimulate epithelial restitution and repair

Proceedings of the National Academy of Sciences - PNAS, 2018-10, Vol.115 (40), p.E9362-E9370

2018

Volltextzugriff (PDF)

Gut Microbiota Profiling and Gut-Brain Crosstalk in Children Affected by Pediatric Acute-Onset Neuropsychiatric Syndrome and Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections

Frontiers in microbiology, 2018-04, Vol.9, p.675-675

2018

Volltextzugriff (PDF)

Fecal transplantation for ulcerative colitis: current evidence and future applications

Expert opinion on biological therapy, 2020-04, Vol.20 (4), p.343-351

2020

Volltextzugriff (PDF)

Opposing Functions of Classic and Novel IL-1 Family Members in Gut Health and Disease

Frontiers in immunology, 2013-01, Vol.4, p.181-181

2013

Volltextzugriff (PDF)

The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin

Digestive diseases (Basel), 2016-01, Vol.34 (3), p.269-278

2016

Volltextzugriff (PDF)

Gut Virome and Inflammatory Bowel Disease

Inflammatory bowel diseases, 2016-07, Vol.22 (7), p.1708-1712

2016

Volltextzugriff (PDF)

Gut microbiota compositional and functional fingerprint in patients with alcohol use disorder and alcohol‐associated liver disease

Liver international, 2020-04, Vol.40 (4), p.878-888

2020

Volltextzugriff (PDF)

Gut Microbiota Modulation and Mucosal Immunity: Focus on Rifaximin

Mini reviews in medicinal chemistry, 2016-01, Vol.16 (3), p.179-185

2016

Volltextzugriff (PDF)

The intriguing role of Rifaximin in gut barrier chronic inflammation and in the treatment of Crohn's disease

Expert opinion on investigational drugs, 2018-06, Vol.27 (6), p.543-551

2018

Volltextzugriff (PDF)

The gastrointestinal microbiome – Functional interference between stomach and intestine

Baillière's best practice & research. Clinical gastroenterology, 2014-12, Vol.28 (6), p.995-1002

2014

Volltextzugriff (PDF)

Emerging role of the interleukin (IL)-33/ST2 axis in gut mucosal wound healing and fibrosis

Fibrogenesis & tissue repair, 2012-10, Vol.5 (1), p.18-18, Article 18

2012

Volltextzugriff (PDF)

Immune system and gut microbiota senescence in elderly IBD patients

Minerva Gastroenterology, 2024-03, Vol.70 (1), p.59

2024

Volltextzugriff (PDF)

Dietary Magnesium Alleviates Experimental Murine Colitis Through Upregulation of the Transient Receptor Potential Melastatin 6 Channel

Inflammatory bowel diseases, 2018-09, Vol.24 (10), p.2198-2210

2018

Volltextzugriff (PDF)

A novel model of colitis-associated cancer in SAMP1/YitFc mice with Crohn's disease-like ileitis

PloS one, 2017-03, Vol.12 (3), p.e0174121-e0174121

2017

Volltextzugriff (PDF)

Bacillus clausii and gut homeostasis: state of the art and future perspectives

Expert review of gastroenterology & hepatology, 2016-08, Vol.10 (8), p.943-948

2016

Volltextzugriff (PDF)

Epithelial-specific Toll-like Receptor (TLR)5 Activation Mediates Barrier Dysfunction in Experimental Ileitis

Inflammatory bowel diseases, 2017-03, Vol.23 (3), p.392-403

2017

Volltextzugriff (PDF)

Considering gut microbiota disturbance in the management of Helicobacter pylori infection

Expert review of gastroenterology & hepatology, 2018-09, Vol.12 (9), p.899-906

2018

Volltextzugriff (PDF)

Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis

World journal of gastroenterology : WJG, 2019-03, Vol.25 (12), p.1465-1477

2019

Volltextzugriff (PDF)

Gut microbiota and inflammatory bowel disease: so far so gut

Minerva Gastroenterology, 2017-12, Vol.63 (4), p.373

2017

Volltextzugriff (PDF)

Infliximab does not increase colonic cancer risk associated to murine chronic colitis

World journal of gastroenterology : WJG, 2016-11, Vol.22 (44), p.9727-9733

2016

Volltextzugriff (PDF)

Su1861 Critical Role of the IL-33/ST2 Axis in Colitis-Associated Colorectal Cancer

Gastroenterology (New York, N.Y. 1943), 2016-04, Vol.150 (4), p.S573-S573

2016

Volltextzugriff (PDF)

Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy

Expert opinion on biological therapy, 2022-02, Vol.22 (2), p.313-320

2022

Volltextzugriff (PDF)

Principles of structures of animal and plant lectins

BBA - General Subjects, 2002-09, Vol.1572 (2), p.198-208

Loris, Remy

2002

Volltextzugriff (PDF)

1 – 25 von 501

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(448)
Mit Volltextzugriff
(420)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Commensal Clostridia: leading players in the maintenance of gut homeostasis

IL-33 promotes recovery from acute colitis by inducing miR-320 to stimulate epithelial restitution and repair

Gut Microbiota Profiling and Gut-Brain Crosstalk in Children Affected by Pediatric Acute-Onset Neuropsychiatric Syndrome and Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections

Fecal transplantation for ulcerative colitis: current evidence and future applications

Opposing Functions of Classic and Novel IL-1 Family Members in Gut Health and Disease

The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin

Gut Virome and Inflammatory Bowel Disease

Gut microbiota compositional and functional fingerprint in patients with alcohol use disorder and alcohol‐associated liver disease

Gut Microbiota Modulation and Mucosal Immunity: Focus on Rifaximin

The intriguing role of Rifaximin in gut barrier chronic inflammation and in the treatment of Crohn's disease

The gastrointestinal microbiome – Functional interference between stomach and intestine

Emerging role of the interleukin (IL)-33/ST2 axis in gut mucosal wound healing and fibrosis

Immune system and gut microbiota senescence in elderly IBD patients

Dietary Magnesium Alleviates Experimental Murine Colitis Through Upregulation of the Transient Receptor Potential Melastatin 6 Channel

A novel model of colitis-associated cancer in SAMP1/YitFc mice with Crohn's disease-like ileitis

Bacillus clausii and gut homeostasis: state of the art and future perspectives

Epithelial-specific Toll-like Receptor (TLR)5 Activation Mediates Barrier Dysfunction in Experimental Ileitis

Considering gut microbiota disturbance in the management of Helicobacter pylori infection

Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis

Gut microbiota and inflammatory bowel disease: so far so gut

Infliximab does not increase colonic cancer risk associated to murine chronic colitis

Su1861 Critical Role of the IL-33/ST2 Axis in Colitis-Associated Colorectal Cancer

Assessment of small intestinal bacterial overgrowth and methane production in patients on chronic proton-pump inhibitor treatment: prevalence and role of rifaximin in its management in primary care

Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy

Principles of structures of animal and plant lectins

Suchergebnisse filtern